Post by
Millionaire94 on Jan 19, 2018 9:43am
WHAT TO EXPECT TODAY
So people were doubting me yesterday but just from the bids you can see this is bound to happen:
EAT, ACB and HIP will soar today. HIP will go over $2.20
CMED to drop below $28
Comment by
Steve555 on Jan 19, 2018 9:44am
This post has been removed in accordance with Community Policy
Comment by
thorgb1 on Jan 19, 2018 10:31am
EAT up marginally, likely be flat or down by close ACB up a bit HIP up marginally, no where near your estimate CMED up big not down 20% like your estimate Moron.
Comment by
SecondLast on Jan 19, 2018 11:35am
Agreed. Option 1: my guess is ACB is negotiating 3:1 and CMED is pushing 4.5:1. At 3:1 thats ~40$ Option 2: CMED oil production can support a billion dollars a year in high margin revenue at full capacity. Math checks out Conclusion: everything will be great
Comment by
DDobbs on Jan 19, 2018 11:37am
I think if we pay 40 bucks for this dead horse we drop under 10 short term!!
Comment by
SecondLast on Jan 19, 2018 11:42am
40$ cash maybe, not in a paper transaction though. There are synergies in the transaction and ACB was willing to put up 4.5:1 shares to get them a month ago
Comment by
thorgb1 on Jan 19, 2018 11:51am
Also note ACB shareholders have already approved the issuance of the full 170M shares to support the full 4.5 ACB shares to 1 CMED offer. Can't see it being under 3 shares. Also now he Globe article was very clear that ACB approached CMED again, and not vice versa. They would not wast their tim doing his an coming in with another low ball offer.
Comment by
thorgb1 on Jan 19, 2018 11:56am
Anybody know offhand the fully diluted share count for combined CMED-HIP entity? I think it was around 37.5M? Trying to figure out what exchange ratio ACB could support with the issuance of 170M shares which they already have approval for.
Comment by
SecondLast on Jan 19, 2018 12:06pm
About 37,635,000 as a combined entity. CMED has ~24.6M
Comment by
GarlicToast on Jan 19, 2018 12:15pm
This post has been removed in accordance with Community Policy
Comment by
Eigen337 on Jan 19, 2018 12:19pm
This post has been removed in accordance with Community Policy
Comment by
SecondLast on Jan 19, 2018 12:31pm
I thought that too but in the latest news release ACB back tracked on HIP saying they were open to negotiations involving HIP. I think HIP opened alot of peoples eyes as to how the retail investor values branding. It has such a stupidly high market cap for the fundamentals, people just like the branding.
Comment by
StrongLong on Jan 19, 2018 1:25pm
Is there somewhere this 170 million is published officially? If that number is true, it supports the 37.5 million (combined CMED HIP) at the original offer of 4.5:1 and without the cap. so, can we really confirm that 170 million shares approved is a fact???
Comment by
StrongLong on Jan 19, 2018 1:51pm
LOTS of garbage lol. I can't find it anywhere either. I live in Van too, should have atrended. Bah
Comment by
Eigen337 on Jan 19, 2018 1:58pm
This post has been removed in accordance with Community Policy
Comment by
MartialArts on Jan 19, 2018 3:49pm
Great find! There is so much happening here it's hard to keep up. 170M shares of ACB for CMED??? That's worth $2.278 BILLION today. CMED has 24.43M shares in return so ACB is about to offer CMED holders $93.25 per share (in ACB shares)!!!!
Comment by
Theresa1973 on Jan 19, 2018 4:27pm
if you don`t mind me asking, what equation would you use to get this answer?
Comment by
Green2017 on Jan 19, 2018 1:31pm
NO WAY VALUED AT $40 , $30 MAYBE
Comment by
NGlong on Jan 19, 2018 1:40pm
Acb will walk away if CMED can release their financials from last quater before next thursday!
Comment by
Cathat on Jan 19, 2018 1:49pm
This post has been removed in accordance with Community Policy
Comment by
DDobbs on Jan 19, 2018 11:36am
Totally disagree. Investigator was bang on. Acb will walk away before they over pay for this Cmed. Offering more than 30 would be overpaying which would cause us to drop short term.
Comment by
Luvtheleafs on Jan 19, 2018 11:41am
Have to agree with instestigator. Cmed is well in over bought territory. Look at the chart. $25 is bottom.
Comment by
SecondLast on Jan 19, 2018 11:49am
Have you ever seen a corporate transaction where the target was not overbought judging by indicators??
Comment by
Shazam75 on Jan 19, 2018 12:23pm
This post has been removed in accordance with Community Policy